星空体育官方入口网站网址大全-登录入口官网

[GetPortalCommentsPageByObjectIdResponse(id=1233433, encodeId=f0a31233433cb, content=审稿速度:1.0 经验分享：4月投稿，5月意见回来，两个审稿人提了很专业的意见，编辑给了修改后重投，一周后重投，5月底给返修，1周后返回后，7月份接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=Dr. JC H, createdTime=Tue Jul 19 17:47:46 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591170, encodeId=46f35911e0ef, content=2月中旬投稿，3月中旬审回两个审稿人一个基本是肯定的，另一个明显是该专业方向做的很精的人，提了几个问题。花了几天时间，把问题中涉及到的一些概念进行了澄清。之后几天又因为格式进行了resubmission。二审大概一个星期，二审意见回来以后是decision pending。半个月后accept。前后正好3个月。总体上，编辑相对负责，审稿人意见中肯。有一个小细节，需要修订的时候没有发邮件，需要随时关注稿件进度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200709/2d78bcb4ecf5494d8c95db0af4b75e43/1cffda29fec94e999d6ed96a58833296.jpg, createdBy=26451993132, createdName=scottzjt, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088558, encodeId=0fe21088558e1, content=讨论中如何凸显文章创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088557, encodeId=840d108855ecc, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962475, encodeId=311a9624e5c8, content=请问选作者时没有第一作者的选项那应该怎么选呢？只有通讯作者，共同作者和提交秘书这三个选项。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6b8a5490729, createdName=临床医学小博士, createdTime=Mon May 03 18:53:57 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578723, encodeId=4e1b5e8723bc, content=难度有点大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538929, encodeId=4df153892934, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531275, encodeId=5fa35312e597, content=我也是9月投稿，至今依然under review，中间发过一次催稿信，编辑说仍然在审稿中，之前几个同事2016上半年投这个杂志，不到一个月一审就结束了，怎么如今这么慢，等的着急啊，各位有何高见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3b11615928, createdName=jsntxt, createdTime=Sat Dec 31 10:31:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531089, encodeId=a4e453108917, content=真的太慢了，9月投稿现在还在under review，你们一审都多长时间啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=998b66973, createdName=fmmulong, createdTime=Mon Dec 26 11:43:00 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528516, encodeId=749f528516ba, content=请问可以并列第一作者吗9413 2016-05-13 发表:: 今年到5分绝对没问题, beContent=9413 2016-05-13 发表:: 今年到5分绝对没问题, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/1a496a1e95db250492ecce875a01a696/0715d0fd14ff0198de2ec2e7385cfb75.jpg, createdBy=d0f71969654, createdName=fm2333, createdTime=Sat Oct 22 11:11:00 CST 2016, time=2016-10-22, status=1, ipAttribution=)]

2022-07-19 Dr. JC H

审稿速度:1.0
经验分享：4月投稿，5月意见回来，两个审稿人提了很专业的意见，编辑给了修改后重投，一周后重投，5月底给返修，1周后返回后，7月份接收

168 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1233433, encodeId=f0a31233433cb, content=审稿速度:1.0 经验分享：4月投稿，5月意见回来，两个审稿人提了很专业的意见，编辑给了修改后重投，一周后重投，5月底给返修，1周后返回后，7月份接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=Dr. JC H, createdTime=Tue Jul 19 17:47:46 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591170, encodeId=46f35911e0ef, content=2月中旬投稿，3月中旬审回两个审稿人一个基本是肯定的，另一个明显是该专业方向做的很精的人，提了几个问题。花了几天时间，把问题中涉及到的一些概念进行了澄清。之后几天又因为格式进行了resubmission。二审大概一个星期，二审意见回来以后是decision pending。半个月后accept。前后正好3个月。总体上，编辑相对负责，审稿人意见中肯。有一个小细节，需要修订的时候没有发邮件，需要随时关注稿件进度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200709/2d78bcb4ecf5494d8c95db0af4b75e43/1cffda29fec94e999d6ed96a58833296.jpg, createdBy=26451993132, createdName=scottzjt, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088558, encodeId=0fe21088558e1, content=讨论中如何凸显文章创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088557, encodeId=840d108855ecc, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962475, encodeId=311a9624e5c8, content=请问选作者时没有第一作者的选项那应该怎么选呢？只有通讯作者，共同作者和提交秘书这三个选项。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6b8a5490729, createdName=临床医学小博士, createdTime=Mon May 03 18:53:57 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578723, encodeId=4e1b5e8723bc, content=难度有点大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538929, encodeId=4df153892934, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531275, encodeId=5fa35312e597, content=我也是9月投稿，至今依然under review，中间发过一次催稿信，编辑说仍然在审稿中，之前几个同事2016上半年投这个杂志，不到一个月一审就结束了，怎么如今这么慢，等的着急啊，各位有何高见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3b11615928, createdName=jsntxt, createdTime=Sat Dec 31 10:31:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531089, encodeId=a4e453108917, content=真的太慢了，9月投稿现在还在under review，你们一审都多长时间啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=998b66973, createdName=fmmulong, createdTime=Mon Dec 26 11:43:00 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528516, encodeId=749f528516ba, content=请问可以并列第一作者吗9413 2016-05-13 发表:: 今年到5分绝对没问题, beContent=9413 2016-05-13 发表:: 今年到5分绝对没问题, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/1a496a1e95db250492ecce875a01a696/0715d0fd14ff0198de2ec2e7385cfb75.jpg, createdBy=d0f71969654, createdName=fm2333, createdTime=Sat Oct 22 11:11:00 CST 2016, time=2016-10-22, status=1, ipAttribution=)]

2020-05-18 scottzjt

2月中旬投稿，3月中旬审回两个审稿人一个基本是肯定的，另一个明显是该专业方向做的很精的人，提了几个问题。花了几天时间，把问题中涉及到的一些概念进行了澄清。之后几天又因为格式进行了resubmission。二审大概一个星期，二审意见回来以后是decision pending。半个月后accept。前后正好3个月。总体上，编辑相对负责，审稿人意见中肯。有一个小细节，需要修订的时候没有发邮件，需要随时关注稿件进度。

168 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1233433, encodeId=f0a31233433cb, content=审稿速度:1.0 经验分享：4月投稿，5月意见回来，两个审稿人提了很专业的意见，编辑给了修改后重投，一周后重投，5月底给返修，1周后返回后，7月份接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=Dr. JC H, createdTime=Tue Jul 19 17:47:46 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591170, encodeId=46f35911e0ef, content=2月中旬投稿，3月中旬审回两个审稿人一个基本是肯定的，另一个明显是该专业方向做的很精的人，提了几个问题。花了几天时间，把问题中涉及到的一些概念进行了澄清。之后几天又因为格式进行了resubmission。二审大概一个星期，二审意见回来以后是decision pending。半个月后accept。前后正好3个月。总体上，编辑相对负责，审稿人意见中肯。有一个小细节，需要修订的时候没有发邮件，需要随时关注稿件进度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200709/2d78bcb4ecf5494d8c95db0af4b75e43/1cffda29fec94e999d6ed96a58833296.jpg, createdBy=26451993132, createdName=scottzjt, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088558, encodeId=0fe21088558e1, content=讨论中如何凸显文章创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088557, encodeId=840d108855ecc, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962475, encodeId=311a9624e5c8, content=请问选作者时没有第一作者的选项那应该怎么选呢？只有通讯作者，共同作者和提交秘书这三个选项。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6b8a5490729, createdName=临床医学小博士, createdTime=Mon May 03 18:53:57 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578723, encodeId=4e1b5e8723bc, content=难度有点大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538929, encodeId=4df153892934, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531275, encodeId=5fa35312e597, content=我也是9月投稿，至今依然under review，中间发过一次催稿信，编辑说仍然在审稿中，之前几个同事2016上半年投这个杂志，不到一个月一审就结束了，怎么如今这么慢，等的着急啊，各位有何高见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3b11615928, createdName=jsntxt, createdTime=Sat Dec 31 10:31:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531089, encodeId=a4e453108917, content=真的太慢了，9月投稿现在还在under review，你们一审都多长时间啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=998b66973, createdName=fmmulong, createdTime=Mon Dec 26 11:43:00 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528516, encodeId=749f528516ba, content=请问可以并列第一作者吗9413 2016-05-13 发表:: 今年到5分绝对没问题, beContent=9413 2016-05-13 发表:: 今年到5分绝对没问题, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/1a496a1e95db250492ecce875a01a696/0715d0fd14ff0198de2ec2e7385cfb75.jpg, createdBy=d0f71969654, createdName=fm2333, createdTime=Sat Oct 22 11:11:00 CST 2016, time=2016-10-22, status=1, ipAttribution=)]

2021-12-29 MS68862005

讨论中如何凸显文章创新性？

79 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1233433, encodeId=f0a31233433cb, content=审稿速度:1.0 经验分享：4月投稿，5月意见回来，两个审稿人提了很专业的意见，编辑给了修改后重投，一周后重投，5月底给返修，1周后返回后，7月份接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=Dr. JC H, createdTime=Tue Jul 19 17:47:46 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591170, encodeId=46f35911e0ef, content=2月中旬投稿，3月中旬审回两个审稿人一个基本是肯定的，另一个明显是该专业方向做的很精的人，提了几个问题。花了几天时间，把问题中涉及到的一些概念进行了澄清。之后几天又因为格式进行了resubmission。二审大概一个星期，二审意见回来以后是decision pending。半个月后accept。前后正好3个月。总体上，编辑相对负责，审稿人意见中肯。有一个小细节，需要修订的时候没有发邮件，需要随时关注稿件进度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200709/2d78bcb4ecf5494d8c95db0af4b75e43/1cffda29fec94e999d6ed96a58833296.jpg, createdBy=26451993132, createdName=scottzjt, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088558, encodeId=0fe21088558e1, content=讨论中如何凸显文章创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088557, encodeId=840d108855ecc, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962475, encodeId=311a9624e5c8, content=请问选作者时没有第一作者的选项那应该怎么选呢？只有通讯作者，共同作者和提交秘书这三个选项。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6b8a5490729, createdName=临床医学小博士, createdTime=Mon May 03 18:53:57 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578723, encodeId=4e1b5e8723bc, content=难度有点大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538929, encodeId=4df153892934, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531275, encodeId=5fa35312e597, content=我也是9月投稿，至今依然under review，中间发过一次催稿信，编辑说仍然在审稿中，之前几个同事2016上半年投这个杂志，不到一个月一审就结束了，怎么如今这么慢，等的着急啊，各位有何高见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3b11615928, createdName=jsntxt, createdTime=Sat Dec 31 10:31:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531089, encodeId=a4e453108917, content=真的太慢了，9月投稿现在还在under review，你们一审都多长时间啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=998b66973, createdName=fmmulong, createdTime=Mon Dec 26 11:43:00 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528516, encodeId=749f528516ba, content=请问可以并列第一作者吗9413 2016-05-13 发表:: 今年到5分绝对没问题, beContent=9413 2016-05-13 发表:: 今年到5分绝对没问题, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/1a496a1e95db250492ecce875a01a696/0715d0fd14ff0198de2ec2e7385cfb75.jpg, createdBy=d0f71969654, createdName=fm2333, createdTime=Sat Oct 22 11:11:00 CST 2016, time=2016-10-22, status=1, ipAttribution=)]

2021-12-28 学医的彭于晏

讨论中我和之前发表文章结果不一致怎么处理？

67 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1233433, encodeId=f0a31233433cb, content=审稿速度:1.0 经验分享：4月投稿，5月意见回来，两个审稿人提了很专业的意见，编辑给了修改后重投，一周后重投，5月底给返修，1周后返回后，7月份接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=Dr. JC H, createdTime=Tue Jul 19 17:47:46 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591170, encodeId=46f35911e0ef, content=2月中旬投稿，3月中旬审回两个审稿人一个基本是肯定的，另一个明显是该专业方向做的很精的人，提了几个问题。花了几天时间，把问题中涉及到的一些概念进行了澄清。之后几天又因为格式进行了resubmission。二审大概一个星期，二审意见回来以后是decision pending。半个月后accept。前后正好3个月。总体上，编辑相对负责，审稿人意见中肯。有一个小细节，需要修订的时候没有发邮件，需要随时关注稿件进度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200709/2d78bcb4ecf5494d8c95db0af4b75e43/1cffda29fec94e999d6ed96a58833296.jpg, createdBy=26451993132, createdName=scottzjt, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088558, encodeId=0fe21088558e1, content=讨论中如何凸显文章创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088557, encodeId=840d108855ecc, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962475, encodeId=311a9624e5c8, content=请问选作者时没有第一作者的选项那应该怎么选呢？只有通讯作者，共同作者和提交秘书这三个选项。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6b8a5490729, createdName=临床医学小博士, createdTime=Mon May 03 18:53:57 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578723, encodeId=4e1b5e8723bc, content=难度有点大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538929, encodeId=4df153892934, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531275, encodeId=5fa35312e597, content=我也是9月投稿，至今依然under review，中间发过一次催稿信，编辑说仍然在审稿中，之前几个同事2016上半年投这个杂志，不到一个月一审就结束了，怎么如今这么慢，等的着急啊，各位有何高见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3b11615928, createdName=jsntxt, createdTime=Sat Dec 31 10:31:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531089, encodeId=a4e453108917, content=真的太慢了，9月投稿现在还在under review，你们一审都多长时间啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=998b66973, createdName=fmmulong, createdTime=Mon Dec 26 11:43:00 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528516, encodeId=749f528516ba, content=请问可以并列第一作者吗9413 2016-05-13 发表:: 今年到5分绝对没问题, beContent=9413 2016-05-13 发表:: 今年到5分绝对没问题, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/1a496a1e95db250492ecce875a01a696/0715d0fd14ff0198de2ec2e7385cfb75.jpg, createdBy=d0f71969654, createdName=fm2333, createdTime=Sat Oct 22 11:11:00 CST 2016, time=2016-10-22, status=1, ipAttribution=)]

2021-05-03 临床医学小博士

请问选作者时没有第一作者的选项那应该怎么选呢？只有通讯作者，共同作者和提交秘书这三个选项。

84 0

[GetPortalCommentsPageByObjectIdResponse(id=1233433, encodeId=f0a31233433cb, content=审稿速度:1.0 经验分享：4月投稿，5月意见回来，两个审稿人提了很专业的意见，编辑给了修改后重投，一周后重投，5月底给返修，1周后返回后，7月份接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=Dr. JC H, createdTime=Tue Jul 19 17:47:46 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591170, encodeId=46f35911e0ef, content=2月中旬投稿，3月中旬审回两个审稿人一个基本是肯定的，另一个明显是该专业方向做的很精的人，提了几个问题。花了几天时间，把问题中涉及到的一些概念进行了澄清。之后几天又因为格式进行了resubmission。二审大概一个星期，二审意见回来以后是decision pending。半个月后accept。前后正好3个月。总体上，编辑相对负责，审稿人意见中肯。有一个小细节，需要修订的时候没有发邮件，需要随时关注稿件进度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200709/2d78bcb4ecf5494d8c95db0af4b75e43/1cffda29fec94e999d6ed96a58833296.jpg, createdBy=26451993132, createdName=scottzjt, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088558, encodeId=0fe21088558e1, content=讨论中如何凸显文章创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088557, encodeId=840d108855ecc, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962475, encodeId=311a9624e5c8, content=请问选作者时没有第一作者的选项那应该怎么选呢？只有通讯作者，共同作者和提交秘书这三个选项。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6b8a5490729, createdName=临床医学小博士, createdTime=Mon May 03 18:53:57 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578723, encodeId=4e1b5e8723bc, content=难度有点大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538929, encodeId=4df153892934, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531275, encodeId=5fa35312e597, content=我也是9月投稿，至今依然under review，中间发过一次催稿信，编辑说仍然在审稿中，之前几个同事2016上半年投这个杂志，不到一个月一审就结束了，怎么如今这么慢，等的着急啊，各位有何高见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3b11615928, createdName=jsntxt, createdTime=Sat Dec 31 10:31:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531089, encodeId=a4e453108917, content=真的太慢了，9月投稿现在还在under review，你们一审都多长时间啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=998b66973, createdName=fmmulong, createdTime=Mon Dec 26 11:43:00 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528516, encodeId=749f528516ba, content=请问可以并列第一作者吗9413 2016-05-13 发表:: 今年到5分绝对没问题, beContent=9413 2016-05-13 发表:: 今年到5分绝对没问题, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/1a496a1e95db250492ecce875a01a696/0715d0fd14ff0198de2ec2e7385cfb75.jpg, createdBy=d0f71969654, createdName=fm2333, createdTime=Sat Oct 22 11:11:00 CST 2016, time=2016-10-22, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

难度有点大

173 0

[GetPortalCommentsPageByObjectIdResponse(id=1233433, encodeId=f0a31233433cb, content=审稿速度:1.0 经验分享：4月投稿，5月意见回来，两个审稿人提了很专业的意见，编辑给了修改后重投，一周后重投，5月底给返修，1周后返回后，7月份接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=Dr. JC H, createdTime=Tue Jul 19 17:47:46 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591170, encodeId=46f35911e0ef, content=2月中旬投稿，3月中旬审回两个审稿人一个基本是肯定的，另一个明显是该专业方向做的很精的人，提了几个问题。花了几天时间，把问题中涉及到的一些概念进行了澄清。之后几天又因为格式进行了resubmission。二审大概一个星期，二审意见回来以后是decision pending。半个月后accept。前后正好3个月。总体上，编辑相对负责，审稿人意见中肯。有一个小细节，需要修订的时候没有发邮件，需要随时关注稿件进度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200709/2d78bcb4ecf5494d8c95db0af4b75e43/1cffda29fec94e999d6ed96a58833296.jpg, createdBy=26451993132, createdName=scottzjt, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088558, encodeId=0fe21088558e1, content=讨论中如何凸显文章创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088557, encodeId=840d108855ecc, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962475, encodeId=311a9624e5c8, content=请问选作者时没有第一作者的选项那应该怎么选呢？只有通讯作者，共同作者和提交秘书这三个选项。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6b8a5490729, createdName=临床医学小博士, createdTime=Mon May 03 18:53:57 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578723, encodeId=4e1b5e8723bc, content=难度有点大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538929, encodeId=4df153892934, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531275, encodeId=5fa35312e597, content=我也是9月投稿，至今依然under review，中间发过一次催稿信，编辑说仍然在审稿中，之前几个同事2016上半年投这个杂志，不到一个月一审就结束了，怎么如今这么慢，等的着急啊，各位有何高见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3b11615928, createdName=jsntxt, createdTime=Sat Dec 31 10:31:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531089, encodeId=a4e453108917, content=真的太慢了，9月投稿现在还在under review，你们一审都多长时间啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=998b66973, createdName=fmmulong, createdTime=Mon Dec 26 11:43:00 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528516, encodeId=749f528516ba, content=请问可以并列第一作者吗9413 2016-05-13 发表:: 今年到5分绝对没问题, beContent=9413 2016-05-13 发表:: 今年到5分绝对没问题, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/1a496a1e95db250492ecce875a01a696/0715d0fd14ff0198de2ec2e7385cfb75.jpg, createdBy=d0f71969654, createdName=fm2333, createdTime=Sat Oct 22 11:11:00 CST 2016, time=2016-10-22, status=1, ipAttribution=)]

2017-07-18 med_wu

过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。

389 0

[GetPortalCommentsPageByObjectIdResponse(id=1233433, encodeId=f0a31233433cb, content=审稿速度:1.0 经验分享：4月投稿，5月意见回来，两个审稿人提了很专业的意见，编辑给了修改后重投，一周后重投，5月底给返修，1周后返回后，7月份接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=Dr. JC H, createdTime=Tue Jul 19 17:47:46 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591170, encodeId=46f35911e0ef, content=2月中旬投稿，3月中旬审回两个审稿人一个基本是肯定的，另一个明显是该专业方向做的很精的人，提了几个问题。花了几天时间，把问题中涉及到的一些概念进行了澄清。之后几天又因为格式进行了resubmission。二审大概一个星期，二审意见回来以后是decision pending。半个月后accept。前后正好3个月。总体上，编辑相对负责，审稿人意见中肯。有一个小细节，需要修订的时候没有发邮件，需要随时关注稿件进度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200709/2d78bcb4ecf5494d8c95db0af4b75e43/1cffda29fec94e999d6ed96a58833296.jpg, createdBy=26451993132, createdName=scottzjt, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088558, encodeId=0fe21088558e1, content=讨论中如何凸显文章创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088557, encodeId=840d108855ecc, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962475, encodeId=311a9624e5c8, content=请问选作者时没有第一作者的选项那应该怎么选呢？只有通讯作者，共同作者和提交秘书这三个选项。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6b8a5490729, createdName=临床医学小博士, createdTime=Mon May 03 18:53:57 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578723, encodeId=4e1b5e8723bc, content=难度有点大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538929, encodeId=4df153892934, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531275, encodeId=5fa35312e597, content=我也是9月投稿，至今依然under review，中间发过一次催稿信，编辑说仍然在审稿中，之前几个同事2016上半年投这个杂志，不到一个月一审就结束了，怎么如今这么慢，等的着急啊，各位有何高见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3b11615928, createdName=jsntxt, createdTime=Sat Dec 31 10:31:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531089, encodeId=a4e453108917, content=真的太慢了，9月投稿现在还在under review，你们一审都多长时间啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=998b66973, createdName=fmmulong, createdTime=Mon Dec 26 11:43:00 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528516, encodeId=749f528516ba, content=请问可以并列第一作者吗9413 2016-05-13 发表:: 今年到5分绝对没问题, beContent=9413 2016-05-13 发表:: 今年到5分绝对没问题, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/1a496a1e95db250492ecce875a01a696/0715d0fd14ff0198de2ec2e7385cfb75.jpg, createdBy=d0f71969654, createdName=fm2333, createdTime=Sat Oct 22 11:11:00 CST 2016, time=2016-10-22, status=1, ipAttribution=)]

2016-12-31 jsntxt

我也是9月投稿，至今依然under review，中间发过一次催稿信，编辑说仍然在审稿中，之前几个同事2016上半年投这个杂志，不到一个月一审就结束了，怎么如今这么慢，等的着急啊，各位有何高见？

357 0

[GetPortalCommentsPageByObjectIdResponse(id=1233433, encodeId=f0a31233433cb, content=审稿速度:1.0 经验分享：4月投稿，5月意见回来，两个审稿人提了很专业的意见，编辑给了修改后重投，一周后重投，5月底给返修，1周后返回后，7月份接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=Dr. JC H, createdTime=Tue Jul 19 17:47:46 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591170, encodeId=46f35911e0ef, content=2月中旬投稿，3月中旬审回两个审稿人一个基本是肯定的，另一个明显是该专业方向做的很精的人，提了几个问题。花了几天时间，把问题中涉及到的一些概念进行了澄清。之后几天又因为格式进行了resubmission。二审大概一个星期，二审意见回来以后是decision pending。半个月后accept。前后正好3个月。总体上，编辑相对负责，审稿人意见中肯。有一个小细节，需要修订的时候没有发邮件，需要随时关注稿件进度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200709/2d78bcb4ecf5494d8c95db0af4b75e43/1cffda29fec94e999d6ed96a58833296.jpg, createdBy=26451993132, createdName=scottzjt, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088558, encodeId=0fe21088558e1, content=讨论中如何凸显文章创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088557, encodeId=840d108855ecc, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962475, encodeId=311a9624e5c8, content=请问选作者时没有第一作者的选项那应该怎么选呢？只有通讯作者，共同作者和提交秘书这三个选项。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6b8a5490729, createdName=临床医学小博士, createdTime=Mon May 03 18:53:57 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578723, encodeId=4e1b5e8723bc, content=难度有点大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538929, encodeId=4df153892934, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531275, encodeId=5fa35312e597, content=我也是9月投稿，至今依然under review，中间发过一次催稿信，编辑说仍然在审稿中，之前几个同事2016上半年投这个杂志，不到一个月一审就结束了，怎么如今这么慢，等的着急啊，各位有何高见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3b11615928, createdName=jsntxt, createdTime=Sat Dec 31 10:31:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531089, encodeId=a4e453108917, content=真的太慢了，9月投稿现在还在under review，你们一审都多长时间啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=998b66973, createdName=fmmulong, createdTime=Mon Dec 26 11:43:00 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528516, encodeId=749f528516ba, content=请问可以并列第一作者吗9413 2016-05-13 发表:: 今年到5分绝对没问题, beContent=9413 2016-05-13 发表:: 今年到5分绝对没问题, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/1a496a1e95db250492ecce875a01a696/0715d0fd14ff0198de2ec2e7385cfb75.jpg, createdBy=d0f71969654, createdName=fm2333, createdTime=Sat Oct 22 11:11:00 CST 2016, time=2016-10-22, status=1, ipAttribution=)]

2016-12-26 fmmulong

真的太慢了，9月投稿现在还在under review，你们一审都多长时间啊

348 0

[GetPortalCommentsPageByObjectIdResponse(id=1233433, encodeId=f0a31233433cb, content=审稿速度:1.0 经验分享：4月投稿，5月意见回来，两个审稿人提了很专业的意见，编辑给了修改后重投，一周后重投，5月底给返修，1周后返回后，7月份接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=Dr. JC H, createdTime=Tue Jul 19 17:47:46 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591170, encodeId=46f35911e0ef, content=2月中旬投稿，3月中旬审回两个审稿人一个基本是肯定的，另一个明显是该专业方向做的很精的人，提了几个问题。花了几天时间，把问题中涉及到的一些概念进行了澄清。之后几天又因为格式进行了resubmission。二审大概一个星期，二审意见回来以后是decision pending。半个月后accept。前后正好3个月。总体上，编辑相对负责，审稿人意见中肯。有一个小细节，需要修订的时候没有发邮件，需要随时关注稿件进度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200709/2d78bcb4ecf5494d8c95db0af4b75e43/1cffda29fec94e999d6ed96a58833296.jpg, createdBy=26451993132, createdName=scottzjt, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088558, encodeId=0fe21088558e1, content=讨论中如何凸显文章创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088557, encodeId=840d108855ecc, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962475, encodeId=311a9624e5c8, content=请问选作者时没有第一作者的选项那应该怎么选呢？只有通讯作者，共同作者和提交秘书这三个选项。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6b8a5490729, createdName=临床医学小博士, createdTime=Mon May 03 18:53:57 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578723, encodeId=4e1b5e8723bc, content=难度有点大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538929, encodeId=4df153892934, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531275, encodeId=5fa35312e597, content=我也是9月投稿，至今依然under review，中间发过一次催稿信，编辑说仍然在审稿中，之前几个同事2016上半年投这个杂志，不到一个月一审就结束了，怎么如今这么慢，等的着急啊，各位有何高见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3b11615928, createdName=jsntxt, createdTime=Sat Dec 31 10:31:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531089, encodeId=a4e453108917, content=真的太慢了，9月投稿现在还在under review，你们一审都多长时间啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=998b66973, createdName=fmmulong, createdTime=Mon Dec 26 11:43:00 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528516, encodeId=749f528516ba, content=请问可以并列第一作者吗9413 2016-05-13 发表:: 今年到5分绝对没问题, beContent=9413 2016-05-13 发表:: 今年到5分绝对没问题, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/1a496a1e95db250492ecce875a01a696/0715d0fd14ff0198de2ec2e7385cfb75.jpg, createdBy=d0f71969654, createdName=fm2333, createdTime=Sat Oct 22 11:11:00 CST 2016, time=2016-10-22, status=1, ipAttribution=)]

2016-10-22 fm2333

请问可以并列第一作者吗9413 2016-05-13 发表::
今年到5分绝对没问题

9413 2016-05-13 发表:: 今年到5分绝对没问题

407 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务